These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 8094282)

  • 21. Significance of c-erbB-2 amplification and DNA aneuploidy. Analysis in 78 patients with node-negative breast cancer.
    Babiak J; Hugh J; Poppema S
    Cancer; 1992 Aug; 70(4):770-6. PubMed ID: 1353701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTEN/PI3K/AKT protein expression is related to clinicopathological features and prognosis in breast cancer with axillary lymph node metastases.
    Wang LL; Hao S; Zhang S; Guo LJ; Hu CY; Zhang G; Gao B; Zhao JJ; Jiang Y; Tian WG; Wang J; Luo DL
    Hum Pathol; 2017 Mar; 61():49-57. PubMed ID: 27864123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flow cytometric analysis of primary tumors and their corresponding metastatic nodes in breast cancer.
    Kang HS; Youn YK; Oh SK; Choe KJ; Noh DY
    Breast Cancer Res Treat; 2000 Sep; 63(1):81-7. PubMed ID: 11079162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual colour flow cytometry of p53 and c-erbB-2 expression related to DNA aneuploidy in primary and metastatic breast cancer.
    Clark JS; George WD; Campbell AM
    Cancer Lett; 1992 Oct; 66(3):193-200. PubMed ID: 1360329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer.
    Yao MS; Kurland BF; Smith AH; Schubert EK; Dunnwald LK; Byrd DR; Mankoff DA
    Ann Surg Oncol; 2007 Oct; 14(10):2985-93. PubMed ID: 17564747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
    Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases.
    Janni W; Rack B; Sommer H; Schmidt M; Strobl B; Rjosk D; Klanner E; Thieleke W; Gerber B; Friese K; Dimpfl T
    J Cancer Res Clin Oncol; 2003 Sep; 129(9):503-10. PubMed ID: 12884027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of tailored treatment for breast cancer patients with internal mammary lymph node metastases.
    Heuts EM; van der Ent FW; Hulsewé KW; von Meyenfeldt MF; Voogd AC
    Breast; 2009 Aug; 18(4):254-8. PubMed ID: 19515565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic indicators for breast cancer patients with one to three regional lymph node metastases, with special reference to alterations in expression levels of bcl-2, p53 and c-erbB-2 proteins.
    Zhang GJ; Tsuda H; Adachi I; Fukutomi T; Yamamoto H; Hirohashi S
    Jpn J Clin Oncol; 1997 Dec; 27(6):371-7. PubMed ID: 9437997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of cancer-related oncoprotein expression as prognostic factors in breast-cancer with one to three axillary lymph nodes positive].
    Zhang G; Tsuda H; Adachi I; Fukutomi T; Yamamoto H; Hirohashi S
    Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():66-74. PubMed ID: 8702314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multivariate study of the relationship between regional lymph node metastases and prognosis in patients with operable breast cancer.
    Noguchi M; Taniya T; Koyasaki N; Ohta N; Miyazaki I
    Jpn J Surg; 1991 Nov; 21(6):613-20. PubMed ID: 1664901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes.
    Veronesi U; Cascinelli N; Greco M; Bufalino R; Morabito A; Galluzzo D; Conti R; De Lellis R; Delle Donne V; Piotti P
    Ann Surg; 1985 Dec; 202(6):702-7. PubMed ID: 3000303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness.
    Brouillet JP; Theillet C; Maudelonde T; Defrenne A; Simony-Lafontaine J; Sertour J; Pujol H; Jeanteur P; Rochefort H
    Eur J Cancer; 1990 Apr; 26(4):437-41. PubMed ID: 2141510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
    Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
    Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer: prognostic significance of c-erb-B2 and int-2 amplification compared with DNA ploidy, S-phase fraction, and conventional clinicopathological features.
    Lönn U; Lönn S; Nilsson B; Stenkvist B
    Breast Cancer Res Treat; 1994; 29(3):237-45. PubMed ID: 7914106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relation of visualization of internal mammary lymph nodes on lymphoscintigraphy to axillary lymph node metastases in breast cancer.
    Kim H; Shin MJ; Kim SJ; Kim IJ; Park I
    Lymphat Res Biol; 2014 Dec; 12(4):295-300. PubMed ID: 25144255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between CSE1L expression and axillary lymph node metastasis in breast cancer.
    Yuksel UM; Dilek G; Dogan L; Gulcelik MA; Berberoglu U
    Tumori; 2015; 101(2):194-8. PubMed ID: 25791533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG-PET for axillary lymph node staging in primary breast cancer.
    Crippa F; Gerali A; Alessi A; Agresti R; Bombardieri E
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.